Because platelets can rise and fall even if your treatment is working, your healthcare team will try to keep your platelet count within a
certain range rather than at an exact number.
You and your doctor will set a target range for your platelet counts. Your doctor may prescribe platelet boosters, which are treatments that
aim to increase your platelet count, to reduce the risk of bleeding. Talk to your doctor about what’s right for you.
The Nplate® Dose and Platelet Tracker can
help you track how your platelet counts are changing throughout your treatment.
When you receive your treatment is up to you. Many patients like to schedule their weekly Nplate® treatments at the same time and day each week.
If you’re planning to travel or relocate, ITP Specialist Finder can help you locate a doctor who may be able to administer your weekly Nplate® treatment.
Your doctor may increase or decrease the dose of your Nplate® injection to keep your platelet level stable.
Your healthcare team will measure your platelet count regularly to make sure you are responding to treatment.
If you miss a scheduled dose of Nplate®, make sure to schedule your next dose as soon as possible.
During your weekly visits, keep your healthcare team updated about any changes you experience or questions you have.
Your doctor will help you understand how long you can expect to receive treatment for ITP. Without stable platelet counts above 50,000 per microliter, the risk of bleeding increases. Speak with your doctor about the importance of sticking with your Nplate® treatment without interruption.
Staying on Nplate® can help raise
and sustain platelet production
over time
For people treated with Nplate® who experienced side effects, the side effects were mild to moderate and did not increase over time.
Important Safety Information
What is the most important information I should know about Nplate®?
Worsening of a precancerous blood condition to a blood cancer (leukemia): Nplate® is not for use in people with a precancerous condition called myelodysplastic syndromes (MDS), or for any condition other than immune thrombocytopenia (ITP). If you have MDS and receive Nplate®, your MDS condition may worsen and become an acute leukemia. If MDS worsens to become acute leukemia you may die sooner from the acute leukemia.
Higher risk for blood clots:
What are the possible side effects of Nplate®?
How will I receive Nplate®?
Nplate® is given as an injection under the skin (subcutaneous) one time each week by your healthcare provider. Your healthcare provider will check your platelet count every week and change your dose of Nplate® as needed. This will continue until your healthcare provider decides that your dose of Nplate® can stay the same. After that, you will need to get blood tests every month. When you stop receiving Nplate®, you will need blood tests for at least 2 weeks to check if your platelet count drops too low.
APPROVED USES
Nplate® is a prescription medicine used to treat low blood platelet counts (thrombocytopenia) in:
Nplate® is not for use in people with a precancerous condition called myelodysplastic syndrome (MDS), or low platelet count caused by any condition other than immune thrombocytopenia (ITP). Nplate® is only used if your low platelet count and medical condition increase your risk of bleeding. Nplate® is used to try to keep your platelet count about 50,000 per microliter in order to lower the risk for bleeding. Nplate® is not used to make your platelet count normal. It is not known if Nplate® works or if it is safe in people under the age of 1.
Please see Prescribing Information and Medication Guide for more information about Nplate® on Nplate.com.
Important Safety Information
What is the most important information I should know about Nplate®?
Worsening of a precancerous blood condition to a blood cancer (leukemia): Nplate® is not for use in people with a precancerous condition called myelodysplastic syndromes (MDS), or for any condition other than immune thrombocytopenia (ITP). If you have MDS and receive Nplate®, your MDS condition may worsen and become an acute leukemia. If MDS worsens to become acute leukemia you may die sooner from the acute leukemia.
Higher risk for blood clots: